Tag Waisman Center
The research is funded through an $11 million Transformative Research grant from the National Institutes of Health, which supports exceptionally innovative or unconventional research projects with the potential to advance their field.
Seth Pollak’s research focuses on the influences of environmental risk factors on children’s brain and behavioral development, with particular focus on emotions and learning.
Researchers from the Waisman Center found that people with fragile X are more likely to also have a variety of circulatory, digestive, metabolic, respiratory, and genital and urinary disorders.
Dolan was instrumental in expansion of the center to include laboratories dedicated to stem cell and gene therapy research, a biomanufacturing facility, a brain imaging center, and new space for the Waisman Early Childhood Program.
Renata Laxova focused on intellectual and developmental disabilities, prenatal diagnosis of birth defects, cancer genetics, and — above all — the relationships between medical professionals and patients.
The vaccine will target those most vulnerable to COVID-19 — namely, the elderly and those with health conditions that weaken their immune system. Phase 1 trials could begin in early 2021 and UW–Madison may be a trial site.
Adults with lower genetic risk for ADHD also reported, on average, higher IQs and educational attainments, shorter or no criminal records, lower body mass index (BMI), and lower rates of depression than adults with middle-to-high genetic risk for ADHD.
UW–Madison's Marsha Mailick led researchers from the Waisman Center and Marshfield Clinic in a study that employed machine learning to mine decades of electronic health records of nearly 20,000 individuals.
It’s not a cure for Down syndrome that Dave Witte and Cristina Delgadillo want for their 5-year-old daughter. But they would be happy if stem cell research at the Waisman Center reduces the complications faced by Olivia, who has had two heart surgeries and a stroke.
UW–Madison researchers have shown that mice making too much of a human protein called AT-1 show signs of early aging and premature death, which are also symptoms of the human disorder progeria.
A UW–Madison lab that makes proteins, antibodies and viruses has begun manufacturing a virus critical to experimental treatments for many genetic conditions.